CLL Cello Health Plc

TIDMCLL

RNS Number : 3045R

Cello Group plc

20 September 2017

20 September 2017

Cello Group plc

("Cello" or "the Company")

Additional Block Listing of Ordinary Shares

The Company announces that an application has been made to the London Stock Exchange for a block admission for 1,252,829 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.

These new Ordinary Shares will be issued and allotted from time to time pursuant to the exercise of existing options under the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010. New Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company.

Admission of the new Ordinary Shares is expected to occur on 26 September 2017.

Enquiries:

 
 Cello Group                       020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Finance Director 
 
 Cenkos Securities                 0207 397 8900 
 Bobbie Hilliam 
  Harry Hargreaves 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ALSPGUUABUPMGUU

(END) Dow Jones Newswires

September 20, 2017 06:52 ET (10:52 GMT)

Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024

Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024